India to Kenya: Hydrochlorothiazide Export Trade Route

The India to Kenya Hydrochlorothiazide corridor is one of India's established pharmaceutical export routes, with 153 shipments documented worth a combined $4.3M USD. The route is dominated by MICRO LABS LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's hydrochlorothiazide manufacturing sector.

Across 28 active suppliers, the average shipment value stands at $28.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 13.2%, placing it at rank #17 among India's top hydrochlorothiazide export destinations globally.

On the import side, key buyers of Indian hydrochlorothiazide in Kenya include M/S LABOREX KENYA LIMITED, ABACUS PHARMA (AFRICA) LTD, M S LABOREX KENYA LIMITED and 55 others. M/S LABOREX KENYA LIMITED is the single largest importer with 23 shipments valued at $1.4M USD.

India's hydrochlorothiazide exports to Kenya are driven primarily by a handful of large-scale manufacturers. MICRO LABS LIMITED with 37 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 28 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MICRO LABS LIMITED, ZYDUS LIFESCIENCES LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 81% of total trade value on this route. The average shipment value of $28.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as amlozaar h - (amlodipine 5mg losartan potassium 50mg & hydrochlorothiazide 12.5mg tablets)( units- 3x10s) (nos)(qty:325 and losacar - h tablet (losartane potassiumand hydrochlorothiazide usp 50/12.5mg) 3x10 t, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, M/S LABOREX KENYA LIMITED is the largest importer with 23 shipments worth $1.4M USD — representing 33% of all hydrochlorothiazide imports from India on this route. A total of 58 buyers are active on this corridor.